옥시코돈약 시장 : 제품 유형, 제형, 적응증, 유통 채널별 - 세계 예측(2024-2032년)

Oxycodone Drugs Market size is projected to record 5.7% CAGR from 2024 to 2032, driven by their growing role in pain management for the aging population. Healthcare providers are carefully prescribing these medications to alleviate chronic pain in elderly patients.

With the expansion of the aging population, there is growing emphasis on monitoring and managing opioid use to mitigate risks of dependency and misuse. According to WHO, by 2050, the world's population of people aged 60 years and older will double to 2.1 billion. Medical professionals are focusing on alternative pain management strategies, such as non-opioid medications and therapies. The ongoing R&D efforts are also creating safer and more effective treatments tailored to the specific needs of older adults for ensuring better long-term outcomes for pain management.

The overall oxycodone drugs market is segregated into drug type, dosage form, indication, distribution channel, and region.

In terms of dosage form, the injections segment is expected to record significant CAGR from 2024 to 2032. Oxycodone injections are used for managing severe pain in patients who require immediate relief. Medical professionals are administering these injections to ensure effective pain control especially in acute care settings. As the incidence of chronic pain increases, healthcare providers are optimizing oxycodone injection protocols to minimize side effects and dependency risks.

By distribution channel, the oxycodone drugs industry from the online pharmacies segment is projected to rise from 2024 to 2032, driven by the easy access to multiple drugs for patients in need of pain management. Online platforms play a crucial role in ensuring that individuals particularly those with mobility issues and can obtain their medications conveniently. These pharmacies are also implementing strict verification processes for enhancing security measures to prevent misuse and ensure proper dispensing.

Regionally, the Asia Pacific oxycodone drugs market size is projected to exhibit robust growth between 2024 and 2032, fueled by increasing healthcare infrastructure development and escalating healthcare expenditure. Governments and private sectors in APAC are investing on modernizing healthcare facilities and expanding access to pain management treatments. The ongoing investments for enhancing the quality and availability of oxycodone for ensuring that patients receive effective and regulated pain relief across the region will also push the product uptake.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increase in the prevalence of chronic pain
    • 3.2.1.2 Increase in incident of trauma and surgeries
    • 3.2.1.3 Rise in geriatric population
    • 3.2.1.4 Advancement in drug delivery system
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Regulatory restrictions
    • 3.2.2.2 Alternative pain management technologies
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Drug Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Short-acting oxycodone
• 5.3 Long-acting oxycodone

Chapter 6 Market Estimates and Forecast, By Dosage Form, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Tablets
• 6.3 Capsules
• 6.4 Injections

Chapter 7 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Neuropathic pain
• 7.3 Musculoskeletal pain
• 7.4 Cancer pain
• 7.5 Post-operative pain
• 7.6 Other indications

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospital pharmacies
• 8.3 Drug stores & retail pharmacies
• 8.4 Online pharmacies

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Alvogen
• 10.2 Ani Pharmaceutical Inc.
• 10.3 Daiichi Sankyo Company Ltd.
• 10.4 Endo Pharmaceuticals
• 10.5 Mallinckrodt Pharmaceuticals
• 10.6 Mylan N.V.
• 10.7 Protega Pharmaceuticals LLC
• 10.8 Purdue Pharma LP
• 10.9 Quagen Pharma
• 10.10 Teva Pharmaceuticals, Inc.